Company intelligence / Profile preview
Tessera Therapeutics
S omerville, Massachusetts, United Statestesseratherapeutics.com ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Preclinical
01
Overview
Tessera Therapeutics has demonstrated preclinical proof-of-concept data using its RNA-based Gene Writers to correct genetic mutations in animal models of several monogenic diseases, including sickle cell disease, alpha‑1 antitrypsin deficiency, phenylketonuria, and Wilson’s disease. The company has also shown the ability to engineer tumor-killing CAR-T cells using its multiplexed approach. No clinical-stage results have been reported as of mid‑2024.[8][9]
- Therapeutic areas
- OncologyHematologyRare DiseasesMetabolic Disorders
- Modalities
- Gene Writing™ (proprietary genome engineering)RNA-based gene editing/engineering[9]Non-viral delivery (lipid nanoparticles)[3][9]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Bill & Melinda Gates Foundation(co-funding SCD program )[3 ][6 ]No major pharma partnerships publicly disclosed as of May2025.
Beyond the preview
Go deeper on Tessera Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tessera Therapeutics.